05.01.2023 • NewsPharmaGreenfieldSustainability

Granules India and Greenko ZeroC Plan Green Pharma Zones

Granules India, a Hyderabad-based pharma company, is partnering compatriot clean energy company Greenko ZeroC to develop green zones for the sustainable manufacture of drugs and their intermediates.

The first zone will be developed in Kakinada, Andra Pradesh, where Granules will build a greenfield facility based on sustainability principles for the large-scale manufacturing of key starting materials, intermediates, APIs and fermentation-based products.    

The cost of the project, which will be implemented in phases, is estimated at $242 million over five years.

Greenko ZeroC will supply carbon-free energy, also enabling the production of green hydrogen and its various chemical derivatives, which Granules will use to make products such as dicyandiamide (DCDA), paracetamol and metformin, among others.

Anil Kumar Chalamalasetty, Greenko’s CEO and managing director, said the “innovative and pioneering partnership will propel the transformation of industrial manufacturing to be more sustainable and competitive.”

Granules India has seven manufacturing facilities in total – six are based in India (Hyderabad and Visakhapatnam) and one is in the US (Chantilly, Virginia).

Author: Elaine Burridge, Freelance Journalist

© Shutterstock/Getty Images
© Shutterstock/Getty Images

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.